Deutsch E - Search Results

1

Transcriptional response to hypoxic stress in melanoma and prognostic potential of GBE1 and BNIP3.

Buart S, Terry S, Noman MZ, Lanoy E, Boutros C, Fogel P, Dessen P, Meurice G, Gaston-Mathé Y, Vielh P, Roy S, Routier E, Marty V, Ferlicot S, Legrès L, Bouchtaoui ME, Kamsu-Kom N, Muret J, Deutsch E, Eggermont A, Soria JC, Robert C, Chouaib S. Buart S, et al. Among authors: deutsch e. Oncotarget. 2017 Oct 30;8(65):108786-108801. doi: 10.18632/oncotarget.22150. eCollection 2017 Dec 12. Oncotarget. 2017. PMID: 29312568 Free PMC article.

2

Chemoprevention of lung cancer.

Soria JC, Kim ES, Fayette J, Lantuejoul S, Deutsch E, Hong WK. Soria JC, et al. Among authors: deutsch e. Lancet Oncol. 2003 Nov;4(11):659-69. doi: 10.1016/s1470-2045(03)01244-0. Lancet Oncol. 2003. PMID: 14602246 Review.

3

Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy.

Loriot Y, Perlemuter G, Malka D, Penault-Llorca F, Boige V, Deutsch E, Massard C, Armand JP, Soria JC. Loriot Y, et al. Among authors: deutsch e. Nat Clin Pract Oncol. 2008 May;5(5):268-78. doi: 10.1038/ncponc1087. Epub 2008 Mar 18. Nat Clin Pract Oncol. 2008. PMID: 18349858 Review.

4

The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials.

Magné N, Chargari C, Castadot P, Ghalibafian M, Soria JC, Haie-Meder C, Bourhis J, Deutsch E. Magné N, et al. Among authors: deutsch e. Eur J Cancer. 2008 Oct;44(15):2133-43. doi: 10.1016/j.ejca.2008.06.029. Epub 2008 Aug 7. Eur J Cancer. 2008. PMID: 18692389 Review.

5

Concomitant chemo-radiotherapy in clinical trials: to promote step by step rational development.

Magné N, Chargari C, Soria JC, Deutsch E. Magné N, et al. Among authors: deutsch e. Crit Rev Oncol Hematol. 2009 Jun;70(3):206-15. doi: 10.1016/j.critrevonc.2008.09.016. Epub 2008 Nov 29. Crit Rev Oncol Hematol. 2009. PMID: 19042138 Review.

6

Are RAS mutations predictive markers of resistance to standard chemotherapy?

Loriot Y, Mordant P, Deutsch E, Olaussen KA, Soria JC. Loriot Y, et al. Among authors: deutsch e. Nat Rev Clin Oncol. 2009 Sep;6(9):528-34. doi: 10.1038/nrclinonc.2009.106. Epub 2009 Jul 14. Nat Rev Clin Oncol. 2009. PMID: 19597509 Review.

7

Dependence on phosphoinositide 3-kinase and RAS-RAF pathways drive the activity of RAF265, a novel RAF/VEGFR2 inhibitor, and RAD001 (Everolimus) in combination.

Mordant P, Loriot Y, Leteur C, Calderaro J, Bourhis J, Wislez M, Soria JC, Deutsch E. Mordant P, et al. Among authors: deutsch e. Mol Cancer Ther. 2010 Feb;9(2):358-68. doi: 10.1158/1535-7163.MCT-09-1014. Epub 2010 Feb 2. Mol Cancer Ther. 2010. PMID: 20124452

8

[Anti-apoptotic mechanisms in small-cell lung carcinoma].

Loriot Y, Calderaro J, Soria JC, Deutsch E, Vielh P. Loriot Y, et al. Among authors: deutsch e. Ann Pathol. 2010 Feb;30(1):17-24. doi: 10.1016/j.annpat.2009.12.005. Epub 2010 Feb 20. Ann Pathol. 2010. PMID: 20223350 French.

9

Inhibition of BCL-2 in small cell lung cancer cell lines with oblimersen, an antisense BCL-2 oligodeoxynucleotide (ODN): in vitro and in vivo enhancement of radiation response.

Loriot Y, Mordant P, Brown BD, Bourhis J, Soria JC, Deutsch E. Loriot Y, et al. Among authors: deutsch e. Anticancer Res. 2010 Oct;30(10):3869-78. Anticancer Res. 2010. PMID: 21036697

10

Minimal residual disease in solid neoplasia: New frontier or red-herring?

Mordant P, Loriot Y, Lahon B, Castier Y, Lesèche G, Soria JC, Massard C, Deutsch E. Mordant P, et al. Among authors: deutsch e. Cancer Treat Rev. 2012 Apr;38(2):101-10. doi: 10.1016/j.ctrv.2011.04.014. Epub 2011 May 25. Cancer Treat Rev. 2012. PMID: 21612875 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,230 results

Search Page

Filters